ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways

Yuan, Hao; Wu, Xuelian; Wang, Xiaomin; Yuan, Chengfu*中国科学院研究生院
Genes & Diseases2022-3DOI: 10.1016/j.gendis.2020.06.001
5被引19阅读
引用收藏
分享

摘要

Astragalus and Angelica decoction (A&A) has been clinically used as a classical traditional Chinese medicine (TCM) formula in China for many years for the treatment of kidney diseases, especially renal interstitial fibrosis (RIF). However, the mechanisms underlying the therapeutic effects of A&A on RIF remains poorly understood. In the present study, systematic network pharmacology and effective experimental verification were utilized for the first time to elucidate the pharmacological efficacy and potential mechanism. The outcomes indicated that 22 active components and 87 target genes of A&A were identified and cross-referenced with RIF-associated genes, contributing to confirmation of 74 target genes of A&A for RIF. Pathway and functional enrichment analyses revealed that A&A had substantial effects on MAPK, PI3K-Akt and TNF signaling pathways. In addition, seven core targets with relatively higher betweenness and degree were identified in the constructed Chinese medicine material-chemical component-target-signal pathway network. Moreover, we verified the potential therapeutic effect of A&A in vivo (using a mouse model of RIF), confirming that A&A could effectively protect the kidney by regulating these target genes. The therapeutic effect of A&A on RIF could be attributed to its role in regulating the cell cycle, limiting the apoptosis, and inhibiting the inflammation.

学科与关键词

关键词
Active componentsAstragalus and angelica decoctionNetwork pharmacologyRenal interstitial fibrosisTarget gene
相关
加载中…
  • Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition
    Liu, Bingran; Deng, Jiankun; Jie, Xina; Lu, Fuhua; Liu, Xusheng*; Zhang, Difei*Journal of Ethnopharmacology, 2022, 293: 115242.被引 4
  • Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT
    Li, Run; Shi, Chunru; Wei, Cuiting; Wang, Chao; Du, Hongjian; Liu, Ran; Wang, Xu; Hong, Quan*; Chen, Xiangmei*PHYTOMEDICINE, 2023, 116: 154873.被引 1
  • Inhibitory Potential of Shen-Shuai-Ling Formulation on Renal Interstitial Fibrosis via Upregulation of PLZF
    Song, Na; Tu, Haitao; Li, Ying*; Xiong, Weijian; Zhang, Ling; Liu, Hong; Ding, Weisen; Long, Mei; Ren, Dewei; Zhong, JinEvidence-based Complementary and Alternative Medicine, 2022, 2022: 5967804.
查看全部 →

发表信息

论文状态
公开发表
期刊
Genes & Diseases
发表日期
2022-03
卷期
第 9 卷, 第 2 期
页码
510-521
DOI
10.1016/j.gendis.2020.06.001
成果收录
SCIE
资助标注
National Nat-ural Science Foundation of China [81773959, 81974528]; Open Foundation for Tumor Microenvironment and Immunotherapy Key Labora-tory of Hubei province in China [2019KZL09]; Health commission of Hubei Province scientific research project in China [WJ2019H527]

作者

  • Y

    Yuan, Hao (第一作者)

    univ chinese acad sci · china three gorges univ

  • W

    Wu, Xuelian

    china three gorges univ

查看全部 4 位作者收起作者
  • W

    Wang, Xiaomin

  • Y

    Yuan, Chengfu (通讯)

    china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417